{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:01:44Z","timestamp":1780117304798,"version":"3.54.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8225\/A21133"],"award-info":[{"award-number":["C8225\/A21133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PRCRPG-Nov21\\\\100001"],"award-info":[{"award-number":["PRCRPG-Nov21\\\\100001"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.radonc.2025.111054","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:50:40Z","timestamp":1754495440000},"page":"111054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The impact of radiotherapy on trials of axillary management in early breast cancer"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5197-7511","authenticated-orcid":false,"given":"Sileida","family":"Oliveros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111054_b0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","article-title":"Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases","volume":"63","author":"Carter","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111054_b0010","first-page":"1551","article-title":"Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer","volume":"52","author":"Fisher","year":"1983","journal-title":"An NSABP update Cancer"},{"key":"10.1016\/j.radonc.2025.111054_b0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-007-9556-1","article-title":"An overview of prognostic factors for long-term survivors of breast cancer","volume":"107","author":"Soerjomataram","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.radonc.2025.111054_b0020","unstructured":"NICE. Early and locally advanced breast cancer: diagnosis and management. NICE guideline [NG101]. 2018 (https:\/\/www.nice.org.uk\/guidance\/ng101)."},{"key":"10.1016\/j.radonc.2025.111054_b0025","doi-asserted-by":"crossref","unstructured":"Gurdeep Mannu GB, Richard Berry, David Dodwell, Robert Hills, Paul McGale, Stewart Anderson, Ian Campbell, Armando E. Giuliano, Reshma Jagsi, Thorsten Kuehn, Rebecca Llewellyn-Bennett, Eleftherios Mamounas, Robert Mansel, Pascal Roy, Emiel Rutgers, Nisha Sharma, Sandra Swain, Jonas Bergh, On behalf of the EBCTCG. Overview of axillary treatment in early breast cancer: Patient-level meta-analysis of long-term outcomes among 20,273 women in 29 randomised trials. AACR; Cancer Res 2024;84(9 Suppl):Abstract nr GS02-05 2023 (https:\/\/doi.org\/10.1158\/1538-7445.SABCS23-GS02-05).","DOI":"10.1158\/1538-7445.SABCS23-GS02-05"},{"key":"10.1016\/j.radonc.2025.111054_b0030","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla - surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"Savolt","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.breast.2023.01.002","article-title":"Omission of axillary sentinel lymph node biopsy in early invasive breast cancer","volume":"67","author":"Reimer","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2025.111054_b0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0050","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2025.111054_b0055","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/cncr.11803","article-title":"Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients","volume":"98","author":"Degnim","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111054_b0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2025.111054_b0065","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2025.111054_b0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sola","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0080","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0085","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1245\/s10434-022-11866-w","article-title":"Preservation of axillary lymph nodes compared with complete dissection in T1-2 Breast cancer patients presenting one or two metastatic sentinel lymph nodes: the SINODAR-ONE multicenter randomized clinical trial","volume":"29","author":"Tinterri","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0090","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.111054_b0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","article-title":"Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial","volume":"17","author":"de Boniface","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111054_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054365","volume":"11","author":"Goyal","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.radonc.2025.111054_b0105","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.clon.2015.07.005","article-title":"POSNOC: a randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases","volume":"27","author":"Goyal","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2025.111054_b0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.breast.2013.02.001","article-title":"Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)\u2013ACOSOG Z0011 results and beyond","volume":"22","author":"Gatzemeier","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2025.111054_b0115","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2014.57.3717","article-title":"Axillary treatment in women with one or two sentinel nodes with macrometastases: more evidence is needed to inform practice","volume":"32","author":"Goyal","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0120","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110372","article-title":"Quality assessment of radiotherapy in the prospective randomized SENOMAC trial","volume":"197","author":"Alkner","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0130","unstructured":"Swedish Breast Cancer Radiotherapy Group. Riktlinjer f\u00f6r volymer och teknik vid str\u00e5lbehandling av br\u00f6stcancer http:\/\/wwwswebcgse\/ 2021;version 5 (https:\/\/www.sciencedirect.com\/science\/article\/pii\/S016781402400642X?via%3Dihub)."},{"key":"10.1016\/j.radonc.2025.111054_b0135","unstructured":"http:\/\/www.dbcg.dk\/. Danish Breast Cancer Group. Retningslinjer - Postoperativ str\u00e5lebehandling af brystkr\u00e6ft Version 3.0. 2022; Available from:. 2022;version 3.0 (https:\/\/www.dbcg.dk\/vaerktoejer\/protokoller\/)."},{"key":"10.1016\/j.radonc.2025.111054_b0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.breast.2022.02.013","article-title":"Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial","volume":"63","author":"Appelgren","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2025.111054_b0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1200\/JCO.2004.12.108","article-title":"Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up","volume":"22","author":"Louis-Sylvestre","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0150","first-page":"163","article-title":"Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial","volume":"87","author":"Chetty","year":"2000","journal-title":"Edinburgh Breast Unit Br J Surg"},{"key":"10.1016\/j.radonc.2025.111054_b0155","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0160","doi-asserted-by":"crossref","unstructured":"Hurkmans CW, Borger JH, Rutgers EJ, van Tienhoven G, Group EBCC, Radiotherapy Cooperative G. Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981\/22023: the dummy run. Radiother Oncol 2003;68(3):233-40. doi: 10.1016\/s0167-8140(03)00194-4.","DOI":"10.1016\/S0167-8140(03)00194-4"},{"key":"10.1016\/j.radonc.2025.111054_b0165","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: sentinel node vs observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2025.111054_b0170","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1245\/ASO.2006.05.013","article-title":"Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial","volume":"13","author":"Wilke","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0175","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejso.2016.01.020","article-title":"Physical function of the upper limb after breast cancer surgery. results from the SOUND (Sentinel node vs. observation after axillary ultra-souND) trial","volume":"42","author":"Gentilini","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0180","first-page":"1557","article-title":"Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial","volume":"9","author":"Gentilini","year":"2023","journal-title":"J Am Med Assoc Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0042-122853","article-title":"Restricted axillary staging in clinically and sonographically node-negative early invasive breast cancer (c\/iT1-2) in the context of breast conserving therapy: first results following commencement of the intergroup-sentinel-mamma (INSEMA) trial","volume":"77","author":"Reimer","year":"2017","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.radonc.2025.111054_b0190","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","article-title":"Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)","volume":"17","author":"van Roozendaal","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111054_b0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12885-022-09273-1","article-title":"No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial","volume":"22","author":"Jung","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111054_b0200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(21)00080-2","article-title":"Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial","volume":"22","author":"Orecchia","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0205","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen international consensus guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0210","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2013dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0215","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.111054_b0220","article-title":"Patient-reported outcomes for the intergroup sentinel mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer","volume":"55","author":"Reimer","year":"2023","journal-title":"E Clin Med"},{"key":"10.1016\/j.radonc.2025.111054_b0225","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","article-title":"Axillary surgery in breast cancer - primary results of the INSEMA trial","volume":"392","author":"Reimer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.111054_b0230","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijrobp.2020.04.042","article-title":"Central review of radiation therapy planning among patients with breast-conserving surgery: results from a quality assurance process integrated into the INSEMA trial","volume":"107","author":"Hildebrandt","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111054_b0235","unstructured":"(RTOG) RTOG. Radiation Therapy Oncology Group. Breast cancer atlas for radiationtherapy planning: Consensus definitions. . 2020 (https:\/\/www.rtog.org\/CoreLab\/ContouringAtlases.aspx)."},{"key":"10.1016\/j.radonc.2025.111054_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110069","article-title":"Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial","volume":"191","author":"Wintraecken","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0245","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2015.12.027","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1","volume":"118","author":"Offersen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0250","article-title":"The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus","volume":"61","author":"Kaidar-Person","year":"2023","journal-title":"E Clin Med"},{"key":"10.1016\/j.radonc.2025.111054_b0255","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","article-title":"Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.111054_b0260","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.111054_b0265","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/cncr.11745","volume":"98","author":"Baum","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111054_b0270","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","volume":"28","author":"Dowsett","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0275","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/bjs.7360","article-title":"Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy","volume":"98","author":"van Wely","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2025.111054_b0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2004.04.065","article-title":"Analysis of axillary coverage during tangential radiation therapy to the breast","volume":"61","author":"Reznik","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111054_b0285","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/SLA.0b013e31827ba02b","article-title":"Are the standard tangential breast irradiation fields used in the ACOSOG Z0011 trial really covering the entire axilla?","volume":"257","author":"Alco","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.radonc.2025.111054_b0290","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1259\/bjr\/25788274","article-title":"Coverage of axillary lymph nodes with high tangential fields in breast radiotherapy","volume":"83","author":"Alco","year":"2010","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2025.111054_b0295","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/bjs.6348","article-title":"False-negative sentinel lymph node biopsy","volume":"95","author":"van Wely","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2025.111054_b0300","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2004.06.006","article-title":"Axillary lymph node dose with tangential breast irradiation","volume":"61","author":"Reed","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111054_b0305","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0360-3016(01)01595-4","article-title":"Evaluation of level I and II axillary nodes included in the standard breast tangential fields and calculation of the administered dose: results of a prospective study","volume":"51","author":"Aristei","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111054_b0310","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0360-3016(00)00449-1","article-title":"Evaluation of a standard breast tangent technique: a dose-volume analysis of tangential irradiation using three-dimensional tools","volume":"47","author":"Krasin","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111054_b0315","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jso.10148","article-title":"Are the axillary lymph nodes treated by standard tangent breast fields?","volume":"81","author":"McCormick","year":"2002","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0320","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0360-3016(01)01684-4","article-title":"Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation","volume":"51","author":"Schlembach","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111054_b0325","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s00066-021-01808-y","article-title":"Incidental axillary dose delivery to axillary lymph node levels I-III by different techniques of whole-breast irradiation: a systematic literature review","volume":"197","author":"Schmitt","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111054_b0330","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1245\/s10434-014-3966-1","article-title":"Breast radiotherapy (RT) using tangential fields (TgF): a prospective evaluation of the dose distribution in the sentinel lymph node (SLN) area as determined intraoperatively by clip placement","volume":"21","author":"Belkacemi","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0335","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075543","article-title":"Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trial","volume":"13","author":"Alkner","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.radonc.2025.111054_b0340","unstructured":"Adrian Murray Brunt* JSH, Duncan A Wheatley et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. The Lancet 2020 (Published online April 28, 2020 https:\/\/doi.org\/10.1016\/S0140-6736(20)30932-6)."},{"key":"10.1016\/j.radonc.2025.111054_b0345","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ejso.2016.02.259","article-title":"Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: a systematic review and an exploratory meta-analysis","volume":"42","author":"Nottegar","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0350","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1200\/JCO-25-00099","article-title":"Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update","volume":"43","author":"Park","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0355","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S1470-2045(24)00350-4","article-title":"Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4\/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial","volume":"25","author":"de Boniface","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0360","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1200\/JCO.19.00761","article-title":"Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer","volume":"37","author":"Sjostrom","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0365","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1200\/JCO.22.00655","article-title":"Development and validation of a genomic profile for the omission of local adjuvant radiation in breast cancer","volume":"41","author":"Sjostrom","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0370","article-title":"RecurIndex-guided postoperative radiotherapy with or without avoidance of irradiation of regional nodes in 1-3 node-positive breast cancer (RIGAIN): a study protocol for a multicentre, open-label, randomised controlled prospective, phase III trial","volume":"14","author":"Liu","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.radonc.2025.111054_b0375","unstructured":"Trials.gov C. Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT). ClinicalTrials.gov ID NCT03488693. 2025 (https:\/\/clinicaltrials.gov\/study\/NCT03488693)."},{"key":"10.1016\/j.radonc.2025.111054_b0380","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1200\/JCO.2006.08.8013","article-title":"Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation","volume":"25","author":"Bevilacqua","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0385","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1245\/ASO.2005.06.037","article-title":"Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram","volume":"12","author":"Specht","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0390","unstructured":"Coles C. PRIMETIME trial.ISRCTN: 41579286. DOI: https:\/\/www.icr.ac.uk\/our-research\/centres-and-collaborations\/centres-at-the-icr\/clinical-trials-and-statistics-unit\/our-research\/clinical-trials\/primetime."},{"key":"10.1016\/j.radonc.2025.111054_b0395","unstructured":"Group BI. EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer (EXPERT). DOI: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02889874."},{"key":"10.1016\/j.radonc.2025.111054_b0400","doi-asserted-by":"crossref","unstructured":"Kunkler I, Linda W, Wilma J, David C, Michael D. Prime 2 randomised trial (postoperative radiotherapy in minimum-risk elderly): Wide local excision and adjuvant hormonal therapy +\/- whole breast irradiation in women =\/> 65 years with early invasive breast cancer: 10 year results. Cancer Res (2021) 81 (4_Supplement): GS2-03 2021 (https:\/\/doi.org\/10.1158\/1538-7445.SABCS20-GS2-03).","DOI":"10.1158\/1538-7445.SABCS20-GS2-03"},{"key":"10.1016\/j.radonc.2025.111054_b0405","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0410","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111054_b0415","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0420","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2022.09.062","article-title":"A meta-analysis of trials of partial breast irradiation","volume":"115","author":"Goldberg","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111054_b0425","first-page":"311","article-title":"Staging of the axilla in breast cancer and the evolving role of axillary ultrasound","volume":"13","author":"Chen","year":"2021","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.radonc.2025.111054_b0430","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10549-022-06583-7","article-title":"Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer","volume":"193","author":"Lemij","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.radonc.2025.111054_b0435","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s12885-023-11122-8","article-title":"Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review","volume":"23","author":"Eliassen","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111054_b0440","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists' Collaborative G. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials. Lancet 2023;402(10416):1991-2003. doi: 10.1016\/S0140-6736(23)01082-6.","DOI":"10.1016\/S0140-6736(23)01082-6"},{"key":"10.1016\/j.radonc.2025.111054_b0445","article-title":"Internal mammary node irradiation in 4541 node-positive breast cancer patients treated with newer systemic therapies and 3D-based radiotherapy (DBCG IMN2): a prospective, nationwide, population-based cohort study","volume":"49","author":"Nielsen","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.radonc.2025.111054_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110060","article-title":"Essential requirements for reporting radiation therapy in breast cancer clinical trials: an international multi-disciplinary consensus endorsed by the European society for radiotherapy and oncology (ESTRO)","volume":"195","author":"Kaidar-Person","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111054_b0455","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-084488","article-title":"Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project","volume":"14","author":"Potter","year":"2024","journal-title":"BMJ Open"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402504558X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402504558X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:20:47Z","timestamp":1780114847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402504558X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":91,"alternative-id":["S016781402504558X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111054","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of radiotherapy on trials of axillary management in early breast cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111054"}}